- Release Date: 20/06/14 15:47
- Summary: RELINT: FPH: Disclosure of Officers Relevant Interests
- Price Sensitive: No
- Download Document 5.55KB
FPH 20/06/2014 15:47 RELINT REL: 1547 HRS Fisher & Paykel Healthcare Corporation Limited RELINT: FPH: Disclosure of Officers Relevant Interests Name of director or officer of public issuer: Deborah Anne BAILEY Name of public issuer: Fisher & Paykel Healthcare Corporation Limited Name of related body corporate (if applicable): Not Applicable Position held in public issuer: Vice President Human Resources B Securities in public issuer or any related body corporate in which director or officer has relevant interest Number, class, and type of securities: Ordinary shares C Nature of relevant interest and name of registered holder Nature of relevant interest in securities: Beneficial Ownership Name of registered holder of securities Deborah Anne BAILEY D Details of acquisitions and disposals If the relevant interest was acquired-- Date of acquisition: Not Applicable Consideration paid for acquisition: Not Applicable If the relevant interest was disposed of-- Date of disposal 18 June 2014 Consideration received for disposal: $56,722.53 Type of transaction Describe the arrangement pursuant to which, or the circumstances in which, the acqusition or disposal took place: Sale of 12,000 ordinary shares E Total number of transactions this notice relates to: One F Date of last disclosure notice (whether in form 1 or form 2) by the director or officer: 6 June 2014 Name of director or officer of public issuer: Lewis George GRADON Name of public issuer: Fisher & Paykel Healthcare Corporation Limited Name of related body corporate (if applicable): Not Applicable Position held in public issuer: Senior VP Products & Technology B Securities in public issuer or any related body corporate in which director or officer has relevant interest Number, class, and type of securities: Ordinary shares and options to acquire ordinary shares C Nature of relevant interest and name of registered holder Nature of relevant interest in securities: Beneficial Ownership Name of registered holder of securities Lewis George GRADON D Details of acquisitions and disposals If the relevant interest was acquired-- Date of acquisition: 19 June 2014 Consideration paid for acquisition: $Nil If the relevant interest was disposed of-- Date of cancellation: 19 June 2014 Consideration received for cancellation: $Nil Type of transaction Describe the arrangement pursuant to which, or the circumstances in which, the acqusition or disposal took place: "Cancellation of 120,000 FPH options and issue of 38,553 ordinary shares" E Total number of transactions this notice relates to: One F Date of last disclosure notice (whether in form 1 or form 2) by the director or officer: 6 June 2014 Name of director or officer of public issuer: Paul Nigel SHEARER Name of public issuer: Fisher & Paykel Healthcare Corporation Limited Name of related body corporate (if applicable): Not Applicable Position held in public issuer: Senior VP Sales & Marketing B Securities in public issuer or any related body corporate in which director or officer has relevant interest Number, class, and type of securities: Ordinary shares and options to acquire ordinary shares C Nature of relevant interest and name of registered holder Nature of relevant interest in securities: Beneficial Ownership Name of registered holder of securities Paul Nigel SHEARER D Details of acquisitions and disposals If the relevant interest was acquired-- Date of acquisition: 19 June 2014 Consideration paid for acquisition: $Nil If the relevant interest was disposed of-- Date of cancellation: 19 June 2014 Consideration received for cancellation: $Nil Type of transaction Describe the arrangement pursuant to which, or the circumstances in which, the acqusition or disposal took place: Cancellation of 120,000 FPH options and issue of 38,553 ordinary shares E Total number of transactions this notice relates to: One F Date of last disclosure notice (whether in form 1 or form 2) by the director or officer: 6 June 2014 Name of director or officer of public issuer: Antony George BARCLAY Name of public issuer: Fisher & Paykel Healthcare Corporation Limited Name of related body corporate (if applicable): Not Applicable Position held in public issuer: Chief Financial Officer & Company Secretary B Securities in public issuer or any related body corporate in which director or officer has relevant interest Number, class, and type of securities: "i) Ordinary shares and options to acquire ordinary shares ii) Ordinary shares iii) Ordinary shares" C Nature of relevant interest and name of registered holder Nature of relevant interest in securities: Beneficial Ownership Name of registered holder of securities Antony George BARCLAY D Details of acquisitions and disposals If the relevant interest was acquired-- Date of acquisition: i) 18/06/2014 Consideration paid for acquisition: $Nil If the relevant interest was disposed of-- Date of cancellation and sale: i) 18 June 2014; ii) 13 June 2014; iii) 18 June 2014 Consideration received for cancellation and sale: i) $Nil; ii) $21,571.20; iii) $126,546.21 Type of transaction Describe the arrangement pursuant to which, or the circumstances in which, the acquisition or disposal took place: "i) Cancellation of 83,334 FPH options and issue of 26,780 ordinary shares; ii) Sale of 4,494 ordinary shares iii) Sale of 26,780 ordinary shares" E Total number of transactions this notice relates to: Three F Date of last disclosure notice (whether in form 1 or form 2) by the director or officer: 6 June 2014 End CA:00251845 For:FPH Type:RELINT Time:2014-06-20 15:47:25
Ann: RELINT: FPH: Disclosure of Officers Relevant Interests
Add to My Watchlist
What is My Watchlist?
